Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda.

Tropical medicine & international health : TM & IH

Nalwoga A, Cose S, Wakeham K, Miley W, Ndibazza J, Drakeley C, Elliott A, Whitby D, Newton R.
PMID: 25611008
Trop Med Int Health. 2015 May;20(5):665-672. doi: 10.1111/tmi.12464. Epub 2015 Feb 09.

OBJECTIVE: Unlike other herpes viruses, Kaposi's sarcoma-associated herpes virus (KSHV) is not ubiquitous worldwide and is most prevalent in sub-Saharan Africa. The reasons for this are unclear. As part of a wider investigation of factors that facilitate transmission in...

Cite
Nalwoga A, Cose S, Wakeham K, et al. Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda. Trop Med Int Health. 2015;20(5):665-672doi: 10.1111/tmi.12464.
Nalwoga, A., Cose, S., Wakeham, K., Miley, W., Ndibazza, J., Drakeley, C., Elliott, A., Whitby, D., & Newton, R. (2015). Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda. Tropical medicine & international health : TM & IH, 20(5), 665-672. https://doi.org/10.1111/tmi.12464
Nalwoga, Angela, et al. "Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda." Tropical medicine & international health : TM & IH vol. 20,5 (2015): 665-672. doi: https://doi.org/10.1111/tmi.12464
Nalwoga A, Cose S, Wakeham K, Miley W, Ndibazza J, Drakeley C, Elliott A, Whitby D, Newton R. Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda. Trop Med Int Health. 2015 May;20(5):665-672. doi: 10.1111/tmi.12464. Epub 2015 Feb 09. PMID: 25611008; PMCID: PMC4390463.
Copy Download .nbib Format: NLM
Comparison of Conventional Smear and Liquid-based Cytology Preparation in Diagnosis of Lung Cancer by Bronchial Wash and Transbronchial Needle Aspiration.

Journal of cytology

Nalwa A, Walia R, Singh V, Madan K, Mathur S, Iyer V, Jain D.
PMID: 29643656
J Cytol. 2018 Apr-Jun;35(2):94-98. doi: 10.4103/JOC.JOC_248_16.

INTRODUCTION: Liquid-based cytology (LBC), initially developed for screening gynecologic specimens, is now being used in nongynecologic aspiration and exfoliative specimens. In this study, the diagnostic yield and utility of thin-prep (TP) was compared with conventional preparations to ascertain its...

Cite
Nalwa A, Walia R, Singh V, et al. Comparison of Conventional Smear and Liquid-based Cytology Preparation in Diagnosis of Lung Cancer by Bronchial Wash and Transbronchial Needle Aspiration. J Cytol. 2018;35(2):94-98doi: 10.4103/JOC.JOC_248_16.
Nalwa, A., Walia, R., Singh, V., Madan, K., Mathur, S., Iyer, V., & Jain, D. (2018). Comparison of Conventional Smear and Liquid-based Cytology Preparation in Diagnosis of Lung Cancer by Bronchial Wash and Transbronchial Needle Aspiration. Journal of cytology, 35(2), 94-98. https://doi.org/10.4103/JOC.JOC_248_16
Nalwa, Aasma, et al. "Comparison of Conventional Smear and Liquid-based Cytology Preparation in Diagnosis of Lung Cancer by Bronchial Wash and Transbronchial Needle Aspiration." Journal of cytology vol. 35,2 (2018): 94-98. doi: https://doi.org/10.4103/JOC.JOC_248_16
Nalwa A, Walia R, Singh V, Madan K, Mathur S, Iyer V, Jain D. Comparison of Conventional Smear and Liquid-based Cytology Preparation in Diagnosis of Lung Cancer by Bronchial Wash and Transbronchial Needle Aspiration. J Cytol. 2018 Apr-Jun;35(2):94-98. doi: 10.4103/JOC.JOC_248_16. PMID: 29643656; PMCID: PMC5885611.
Copy Download .nbib Format: NLM
Variation in KSHV prevalence between geographically proximate locations in Uganda.

Infectious agents and cancer

Nalwoga A, Webb EL, Muserere C, Chihota B, Miley W, Labo N, Elliott A, Cose S, Whitby D, Newton R.
PMID: 32714434
Infect Agent Cancer. 2020 Jul 23;15:49. doi: 10.1186/s13027-020-00313-8. eCollection 2020.

Kaposi's sarcoma-associated herpesvirus (KSHV) transmission within endemic areas may vary. KSHV seroprevalence has been studied by different groups of researchers using different methods, making it difficult to make direct comparisons. Here we show results on KSHV seroprevalence using the...

Cite
Nalwoga A, Webb EL, Muserere C, et al. Variation in KSHV prevalence between geographically proximate locations in Uganda. Infect Agent Cancer. 2020;15:49doi: 10.1186/s13027-020-00313-8.
Nalwoga, A., Webb, E. L., Muserere, C., Chihota, B., Miley, W., Labo, N., Elliott, A., Cose, S., Whitby, D., & Newton, R. (2020). Variation in KSHV prevalence between geographically proximate locations in Uganda. Infectious agents and cancer, 1549. https://doi.org/10.1186/s13027-020-00313-8
Nalwoga, Angela, et al. "Variation in KSHV prevalence between geographically proximate locations in Uganda." Infectious agents and cancer vol. 15 (2020): 49. doi: https://doi.org/10.1186/s13027-020-00313-8
Nalwoga A, Webb EL, Muserere C, Chihota B, Miley W, Labo N, Elliott A, Cose S, Whitby D, Newton R. Variation in KSHV prevalence between geographically proximate locations in Uganda. Infect Agent Cancer. 2020 Jul 23;15:49. doi: 10.1186/s13027-020-00313-8. eCollection 2020. PMID: 32714434; PMCID: PMC7376633.
Copy Download .nbib Format: NLM
Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.

Journal of obstetrics and gynaecology of India

Gothwal M, Nalwa A, Singh P, Yadav G, Bhati M, Samriya N.
PMID: 33814802
J Obstet Gynaecol India. 2021 Feb;71(1):72-77. doi: 10.1007/s13224-020-01380-y. Epub 2020 Nov 18.

INTRODUCTION: Cervical cancer is the most common cancer in India. Screening for cervical cancer helps in marked reduction of invasive cervical cancers. The low sensitivity of Papanicolaou cytology (Pap smear) and high-risk human papillomavirus (HR-HPV) in excluding high-grade intraepithelial...

Cite
Gothwal M, Nalwa A, Singh P, et al. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear. J Obstet Gynaecol India. 2020;71(1):72-77doi: 10.1007/s13224-020-01380-y.
Gothwal, M., Nalwa, A., Singh, P., Yadav, G., Bhati, M., & Samriya, N. (2021). Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear. Journal of obstetrics and gynaecology of India, 71(1), 72-77. https://doi.org/10.1007/s13224-020-01380-y
Gothwal, Meenakshi, et al. "Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear." Journal of obstetrics and gynaecology of India vol. 71,1 (2021): 72-77. doi: https://doi.org/10.1007/s13224-020-01380-y
Gothwal M, Nalwa A, Singh P, Yadav G, Bhati M, Samriya N. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear. J Obstet Gynaecol India. 2021 Feb;71(1):72-77. doi: 10.1007/s13224-020-01380-y. Epub 2020 Nov 18. PMID: 33814802; PMCID: PMC7960869.
Copy Download .nbib Format: NLM
Colorectal Cancer in Uganda: A 10-Year, Facility-Based, Retrospective Study.

Cancer management and research

Wekha G, Ssewante N, Iradukunda A, Jurua M, Nalwoga S, Lanyero S, Olum R, Bongomin F.
PMID: 34675666
Cancer Manag Res. 2021 Oct 07;13:7697-7707. doi: 10.2147/CMAR.S334226. eCollection 2021.

INTRODUCTION: Colorectal cancer (CRC) is the most common type of gastrointestinal malignancies and the third leading cause of cancer-related deaths for both sexes worldwide. Although the burden of CRC is highest in developed countries, reports are indicating a rise...

Cite
Wekha G, Ssewante N, Iradukunda A, et al. Colorectal Cancer in Uganda: A 10-Year, Facility-Based, Retrospective Study. Cancer Manag Res. 2021;13:7697-7707doi: 10.2147/CMAR.S334226.
Wekha, G., Ssewante, N., Iradukunda, A., Jurua, M., Nalwoga, S., Lanyero, S., Olum, R., & Bongomin, F. (2021). Colorectal Cancer in Uganda: A 10-Year, Facility-Based, Retrospective Study. Cancer management and research, 137697-7707. https://doi.org/10.2147/CMAR.S334226
Wekha, Godfrey, et al. "Colorectal Cancer in Uganda: A 10-Year, Facility-Based, Retrospective Study." Cancer management and research vol. 13 (2021): 7697-7707. doi: https://doi.org/10.2147/CMAR.S334226
Wekha G, Ssewante N, Iradukunda A, Jurua M, Nalwoga S, Lanyero S, Olum R, Bongomin F. Colorectal Cancer in Uganda: A 10-Year, Facility-Based, Retrospective Study. Cancer Manag Res. 2021 Oct 07;13:7697-7707. doi: 10.2147/CMAR.S334226. eCollection 2021. PMID: 34675666; PMCID: PMC8504868.
Copy Download .nbib Format: NLM
Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience.

CytoJournal

Bharti JN, Elhence P, Rao M, Nalwa A, Khera S.
PMID: 34512790
Cytojournal. 2021 Aug 02;18:19. doi: 10.25259/Cytojournal_26_2020. eCollection 2021.

OBJECTIVES: The Milan system for reporting salivary gland cytopathology (MSRSGC) classification has been proposed to improve reproducibility in the management of salivary gland lesions. Fine-needle aspiration cytology (FNAC) is a widely accepted, well-tolerated, cost-effective, minimally invasive diagnostic method for...

Cite
Bharti JN, Elhence P, Rao M, et al. Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience. Cytojournal. 2021;18:19doi: 10.25259/Cytojournal_26_2020.
Bharti, J. N., Elhence, P., Rao, M., Nalwa, A., & Khera, S. (2021). Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience. CytoJournal, 1819. https://doi.org/10.25259/Cytojournal_26_2020
Bharti, Jyotsna Naresh, et al. "Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience." CytoJournal vol. 18 (2021): 19. doi: https://doi.org/10.25259/Cytojournal_26_2020
Bharti JN, Elhence P, Rao M, Nalwa A, Khera S. Risk stratification by application of Milan system for reporting salivary gland cytopathology: A tertiary care experience. Cytojournal. 2021 Aug 02;18:19. doi: 10.25259/Cytojournal_26_2020. eCollection 2021. PMID: 34512790; PMCID: PMC8422464.
Copy Download .nbib Format: NLM
Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome: A Case Report and Review of Cases Reported from India.

Indian dermatology online journal

Bains A, Vedant D, Verma A, Bhardwaj A, Nalwa A.
PMID: 31807449
Indian Dermatol Online J. 2019 Nov 01;10(6):686-691. doi: 10.4103/idoj.IDOJ_19_19. eCollection 2019.

Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome is characterized by the triad of follicular keratotic papules, total to subtotal alopecia, and photophobia. We hereby report a case of IFAP syndrome in a 1-year-old boy who presented with all these...

Cite
Bains A, Vedant D, Verma A, et al. Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome: A Case Report and Review of Cases Reported from India. Indian Dermatol Online J. 2019;10(6):686-691doi: 10.4103/idoj.IDOJ_19_19.
Bains, A., Vedant, D., Verma, A., Bhardwaj, A., & Nalwa, A. (2019). Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome: A Case Report and Review of Cases Reported from India. Indian dermatology online journal, 10(6), 686-691. https://doi.org/10.4103/idoj.IDOJ_19_19
Bains, Anupama, et al. "Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome: A Case Report and Review of Cases Reported from India." Indian dermatology online journal vol. 10,6 (2019): 686-691. doi: https://doi.org/10.4103/idoj.IDOJ_19_19
Bains A, Vedant D, Verma A, Bhardwaj A, Nalwa A. Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome: A Case Report and Review of Cases Reported from India. Indian Dermatol Online J. 2019 Nov 01;10(6):686-691. doi: 10.4103/idoj.IDOJ_19_19. eCollection 2019. PMID: 31807449; PMCID: PMC6859747.
Copy Download .nbib Format: NLM
Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda.

Nature communications

Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D.
PMID: 34916520
Nat Commun. 2021 Dec 16;12(1):7323. doi: 10.1038/s41467-021-27623-8.

T cell responses to Kaposi's sarcoma-associated herpesvirus (KSHV) are likely essential in the control of KSHV infection and protection from associated disease, but remain poorly characterised. KSHV prevalence in rural Uganda is high at >90%. Here we investigate IFN-...

Cite
Nalwoga A, Roshan R, Moore K, et al. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun. 2021;12(1):7323doi: 10.1038/s41467-021-27623-8.
Nalwoga, A., Roshan, R., Moore, K., Marshall, V., Miley, W., Labo, N., Nakibuule, M., Cose, S., Rochford, R., Newton, R., & Whitby, D. (2021). Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nature communications, 12(1), 7323. https://doi.org/10.1038/s41467-021-27623-8
Nalwoga, Angela, et al. "Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda." Nature communications vol. 12,1 (2021): 7323. doi: https://doi.org/10.1038/s41467-021-27623-8
Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun. 2021 Dec 16;12(1):7323. doi: 10.1038/s41467-021-27623-8. PMID: 34916520.
Copy Download .nbib Format: NLM
Cross-sectional study of IgG antibody levels to invasive nontyphoidal .

Gates open research

Stockdale L, Nalwoga A, Nash S, Elias S, Asiki G, Kusemererwa S, Gilchrist JJ, Newton R, MacLennan CA.
PMID: 31410397
Gates Open Res. 2019 Jun 26;3:1501. doi: 10.12688/gatesopenres.13034.1. eCollection 2019.

Invasive nontyphoidal

Cite
Stockdale L, Nalwoga A, Nash S, et al. Cross-sectional study of IgG antibody levels to invasive nontyphoidal . Gates Open Res. 2019;3:1501doi: 10.12688/gatesopenres.13034.1.
Stockdale, L., Nalwoga, A., Nash, S., Elias, S., Asiki, G., Kusemererwa, S., Gilchrist, J. J., Newton, R., & MacLennan, C. A. (2019). Cross-sectional study of IgG antibody levels to invasive nontyphoidal . Gates open research, 31501. https://doi.org/10.12688/gatesopenres.13034.1
Stockdale, Lisa, et al. "Cross-sectional study of IgG antibody levels to invasive nontyphoidal ." Gates open research vol. 3 (2019): 1501. doi: https://doi.org/10.12688/gatesopenres.13034.1
Stockdale L, Nalwoga A, Nash S, Elias S, Asiki G, Kusemererwa S, Gilchrist JJ, Newton R, MacLennan CA. Cross-sectional study of IgG antibody levels to invasive nontyphoidal . Gates Open Res. 2019 Jun 26;3:1501. doi: 10.12688/gatesopenres.13034.1. eCollection 2019. PMID: 31410397; PMCID: PMC6640003.
Copy Download .nbib Format: NLM
Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda.

Nature communications

Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D.
PMID: 34916520
Nat Commun. 2021 Dec 16;12(1):7323. doi: 10.1038/s41467-021-27623-8.

T cell responses to Kaposi's sarcoma-associated herpesvirus (KSHV) are likely essential in the control of KSHV infection and protection from associated disease, but remain poorly characterised. KSHV prevalence in rural Uganda is high at >90%. Here we investigate IFN-...

Cite
Nalwoga A, Roshan R, Moore K, et al. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun. 2021;12(1):7323doi: 10.1038/s41467-021-27623-8.
Nalwoga, A., Roshan, R., Moore, K., Marshall, V., Miley, W., Labo, N., Nakibuule, M., Cose, S., Rochford, R., Newton, R., & Whitby, D. (2021). Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nature communications, 12(1), 7323. https://doi.org/10.1038/s41467-021-27623-8
Nalwoga, Angela, et al. "Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda." Nature communications vol. 12,1 (2021): 7323. doi: https://doi.org/10.1038/s41467-021-27623-8
Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun. 2021 Dec 16;12(1):7323. doi: 10.1038/s41467-021-27623-8. PMID: 34916520; PMCID: PMC8677732.
Copy Download .nbib Format: NLM
Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda.

Nature communications

Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D.
PMID: 34916520
Nat Commun. 2021 Dec 16;12(1):7323. doi: 10.1038/s41467-021-27623-8.

T cell responses to Kaposi's sarcoma-associated herpesvirus (KSHV) are likely essential in the control of KSHV infection and protection from associated disease, but remain poorly characterised. KSHV prevalence in rural Uganda is high at >90%. Here we investigate IFN-...

Cite
Nalwoga A, Roshan R, Moore K, et al. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun. 2021;12(1):7323doi: 10.1038/s41467-021-27623-8.
Nalwoga, A., Roshan, R., Moore, K., Marshall, V., Miley, W., Labo, N., Nakibuule, M., Cose, S., Rochford, R., Newton, R., & Whitby, D. (2021). Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nature communications, 12(1), 7323. https://doi.org/10.1038/s41467-021-27623-8
Nalwoga, Angela, et al. "Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda." Nature communications vol. 12,1 (2021): 7323. doi: https://doi.org/10.1038/s41467-021-27623-8
Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun. 2021 Dec 16;12(1):7323. doi: 10.1038/s41467-021-27623-8. PMID: 34916520.
Copy Download .nbib Format: NLM
Hystrix-like linear porokeratosis: a clinicopathological challenge.

International journal of dermatology

Ansari F, Mudugal R, Singh S, Bharti S, Bharti JN, Nalwa A.
PMID: 34176117
Int J Dermatol. 2021 Jun 26; doi: 10.1111/ijd.15711. Epub 2021 Jun 26.

No abstract available.

Cite
Ansari F, Mudugal R, Singh S, et al. Hystrix-like linear porokeratosis: a clinicopathological challenge. Int J Dermatol. 2021;doi: 10.1111/ijd.15711.
Ansari, F., Mudugal, R., Singh, S., Bharti, S., Bharti, J. N., & Nalwa, A. (2021). Hystrix-like linear porokeratosis: a clinicopathological challenge. International journal of dermatology, . https://doi.org/10.1111/ijd.15711
Ansari, Farzana, et al. "Hystrix-like linear porokeratosis: a clinicopathological challenge." International journal of dermatology vol. (2021). doi: https://doi.org/10.1111/ijd.15711
Ansari F, Mudugal R, Singh S, Bharti S, Bharti JN, Nalwa A. Hystrix-like linear porokeratosis: a clinicopathological challenge. Int J Dermatol. 2021 Jun 26; doi: 10.1111/ijd.15711. Epub 2021 Jun 26. PMID: 34176117.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries